The estimated Net Worth of Edward Borkowski is at least $467 Tausend dollars as of 10 May 2021. Mr. Borkowski owns over 103,500 units of AzurRx BioPharma Inc stock worth over $357,075 and over the last 8 years he sold AZRX stock worth over $0. In addition, he makes $109,850 as Independent Chairman of the Board at AzurRx BioPharma Inc.
Sign up
Mr. Borkowski AZRX stock SEC Form 4 insiders trading
Edward has made over 2 trades of the AzurRx BioPharma Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 103,500 units of AZRX stock worth $357,075 on 10 May 2021.
The largest trade he's ever made was exercising 103,500 units of AzurRx BioPharma Inc stock on 10 May 2021 worth over $357,075. On average, Edward trades about 6,643 units every 58 days since 2017. As of 10 May 2021 he still owns at least 103,500 units of AzurRx BioPharma Inc stock.
You can see the complete history of Mr. Borkowski stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Edward Borkowski biography
Edward J. Borkowski CPA serves as Independent Chairman of the Board of the Company. Mr. Borkowski is a healthcare executive who currently serves as Executive Vice President for Therapeutics MD. He served as Executive Vice President of MiMedx Group, Inc. (Nasdaq: MDGX) from April 2018 until December 2019. Mr. Borkowski also served as a director for Co-Diagnostics, Inc. (Nasdaq: CODX), from May 2017 until June 2019. Previously, he served as the Chief Financial Officer of Aceto Corporation (Nasdaq: ACET) from February 2018 to April 2018, and has held several executive positions with Concordia International, an international specialty pharmaceutical company, between May 2015 to February 2018. Mr. Borkowski has also served as Chief Financial Officer of Amerigen Pharmaceuticals, a generic pharmaceutical company with a focus on oral, controlled release products and as the Chief Financial Officer and Executive Vice President of Mylan N.V. In addition, Mr. Borkowski previously held the position of Chief Financial Officer with Convatec, a global medical device company focused on wound care and ostomy, and Carefusion, a global medical device company for which he helped lead its spin-out from Cardinal Health into an independent public company. Mr. Borkowski has also served in senior financial positions at Pharmacia and American Home Products (Wyeth). He started his career with Arthur Andersen & Co. after receiving his MBA in accounting from Rutgers University subsequent to having earned his degree in Economics and Political Science from Allegheny College. Mr. Borkowski is currently a Trustee and a member of the Executive Committee of Allegheny College.
What is the salary of Edward Borkowski?
As the Independent Chairman of the Board of AzurRx BioPharma Inc, the total compensation of Edward Borkowski at AzurRx BioPharma Inc is $109,850. There are 4 executives at AzurRx BioPharma Inc getting paid more, with James R. Sapirstein R.Ph., M.B.A. having the highest compensation of $622,005.
How old is Edward Borkowski?
Edward Borkowski is 60, he's been the Independent Chairman of the Board of AzurRx BioPharma Inc since 2015. There are 4 older and 4 younger executives at AzurRx BioPharma Inc. The oldest executive at AzurRx BioPharma Inc is Vern Schramm, 78, who is the Independent Director.
What's Edward Borkowski's mailing address?
Edward's mailing address filed with the SEC is 951 YAMATO ROAD, SUITE 220, , BOCA RATON, FL, 33431.
Insiders trading at AzurRx BioPharma Inc
Over the last 8 years, insiders at AzurRx BioPharma Inc have traded over $510,400 worth of AzurRx BioPharma Inc stock and bought 335,700 units worth $727,436 . The most active insiders traders include Charles J Casamento, Edmund Burke Jr. Ross und Partners Llcbalk Matthew Pe.... On average, AzurRx BioPharma Inc executives and independent directors trade stock every 82 days with the average trade being worth of $262,052. The most recent stock trade was executed by Johan M. Spoor on 28 December 2018, trading 38,583 units of AZRX stock currently worth $50,158.
What does AzurRx BioPharma Inc's logo look like?
Complete history of Mr. Borkowski stock trades at AzurRx BioPharma Inc, MiMedx Inc und TherapeuticsMD
AzurRx BioPharma Inc executives and stock owners
AzurRx BioPharma Inc executives and other stock owners filed with the SEC include:
-
James R. Sapirstein R.Ph., M.B.A.,
CEO, Pres & Non-Independent Director -
James Pennington,
Chief Medical Officer -
James Sapirstein,
President, Chief Executive Officer, Director -
Alastair Riddell,
Independent Director -
Edward Borkowski,
Independent Chairman of the Board -
Vern Schramm,
Independent Director -
Charles Casamento,
Independent Director -
Gregory Oakes,
Independent Director -
Daniel Schneiderman,
Chief Financial Officer -
Martin Krusin M.B.A.,
Sr. VP of Corp. Devel. -
Johan M. Spoor,
-
Partners Llcbalk Matthew Pe...,
-
Edmund Burke Jr. Ross,
-
Maged Shenouda,
CHIEF FINANCIAL OFFICER -
Daniel Dupret,
CHIEF SCIENTIFIC OFFICER -
Mary Theresa Coelho,